Cargando…
PB1902: FIRST EUROPEAN REAL-WORLD EVIDENCE PROSPECTIVE REGISTRY OF TAGRAXOFUSP, A CD123-DIRECTED THERAPY, FOR THE TREATMENT OF FIRST-LINE ADULT PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429977/ http://dx.doi.org/10.1097/01.HS9.0000974432.10674.cc |
| _version_ | 1785090846426660864 |
|---|---|
| author | Platzbecker, Uwe Angelucci, Emanuele Montesinos, Pau Lemoni, Roberto M. Spyridonidis, Alexandros Riggi, Marcello Zuurman, Michael Mohty, Mohamad |
| author_facet | Platzbecker, Uwe Angelucci, Emanuele Montesinos, Pau Lemoni, Roberto M. Spyridonidis, Alexandros Riggi, Marcello Zuurman, Michael Mohty, Mohamad |
| author_sort | Platzbecker, Uwe |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429977 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104299772023-08-17 PB1902: FIRST EUROPEAN REAL-WORLD EVIDENCE PROSPECTIVE REGISTRY OF TAGRAXOFUSP, A CD123-DIRECTED THERAPY, FOR THE TREATMENT OF FIRST-LINE ADULT PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM Platzbecker, Uwe Angelucci, Emanuele Montesinos, Pau Lemoni, Roberto M. Spyridonidis, Alexandros Riggi, Marcello Zuurman, Michael Mohty, Mohamad Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429977/ http://dx.doi.org/10.1097/01.HS9.0000974432.10674.cc Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Platzbecker, Uwe Angelucci, Emanuele Montesinos, Pau Lemoni, Roberto M. Spyridonidis, Alexandros Riggi, Marcello Zuurman, Michael Mohty, Mohamad PB1902: FIRST EUROPEAN REAL-WORLD EVIDENCE PROSPECTIVE REGISTRY OF TAGRAXOFUSP, A CD123-DIRECTED THERAPY, FOR THE TREATMENT OF FIRST-LINE ADULT PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM |
| title | PB1902: FIRST EUROPEAN REAL-WORLD EVIDENCE PROSPECTIVE REGISTRY OF TAGRAXOFUSP, A CD123-DIRECTED THERAPY, FOR THE TREATMENT OF FIRST-LINE ADULT PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM |
| title_full | PB1902: FIRST EUROPEAN REAL-WORLD EVIDENCE PROSPECTIVE REGISTRY OF TAGRAXOFUSP, A CD123-DIRECTED THERAPY, FOR THE TREATMENT OF FIRST-LINE ADULT PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM |
| title_fullStr | PB1902: FIRST EUROPEAN REAL-WORLD EVIDENCE PROSPECTIVE REGISTRY OF TAGRAXOFUSP, A CD123-DIRECTED THERAPY, FOR THE TREATMENT OF FIRST-LINE ADULT PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM |
| title_full_unstemmed | PB1902: FIRST EUROPEAN REAL-WORLD EVIDENCE PROSPECTIVE REGISTRY OF TAGRAXOFUSP, A CD123-DIRECTED THERAPY, FOR THE TREATMENT OF FIRST-LINE ADULT PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM |
| title_short | PB1902: FIRST EUROPEAN REAL-WORLD EVIDENCE PROSPECTIVE REGISTRY OF TAGRAXOFUSP, A CD123-DIRECTED THERAPY, FOR THE TREATMENT OF FIRST-LINE ADULT PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM |
| title_sort | pb1902: first european real-world evidence prospective registry of tagraxofusp, a cd123-directed therapy, for the treatment of first-line adult patients with blastic plasmacytoid dendritic cell neoplasm |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429977/ http://dx.doi.org/10.1097/01.HS9.0000974432.10674.cc |
| work_keys_str_mv | AT platzbeckeruwe pb1902firsteuropeanrealworldevidenceprospectiveregistryoftagraxofuspacd123directedtherapyforthetreatmentoffirstlineadultpatientswithblasticplasmacytoiddendriticcellneoplasm AT angelucciemanuele pb1902firsteuropeanrealworldevidenceprospectiveregistryoftagraxofuspacd123directedtherapyforthetreatmentoffirstlineadultpatientswithblasticplasmacytoiddendriticcellneoplasm AT montesinospau pb1902firsteuropeanrealworldevidenceprospectiveregistryoftagraxofuspacd123directedtherapyforthetreatmentoffirstlineadultpatientswithblasticplasmacytoiddendriticcellneoplasm AT lemonirobertom pb1902firsteuropeanrealworldevidenceprospectiveregistryoftagraxofuspacd123directedtherapyforthetreatmentoffirstlineadultpatientswithblasticplasmacytoiddendriticcellneoplasm AT spyridonidisalexandros pb1902firsteuropeanrealworldevidenceprospectiveregistryoftagraxofuspacd123directedtherapyforthetreatmentoffirstlineadultpatientswithblasticplasmacytoiddendriticcellneoplasm AT riggimarcello pb1902firsteuropeanrealworldevidenceprospectiveregistryoftagraxofuspacd123directedtherapyforthetreatmentoffirstlineadultpatientswithblasticplasmacytoiddendriticcellneoplasm AT zuurmanmichael pb1902firsteuropeanrealworldevidenceprospectiveregistryoftagraxofuspacd123directedtherapyforthetreatmentoffirstlineadultpatientswithblasticplasmacytoiddendriticcellneoplasm AT mohtymohamad pb1902firsteuropeanrealworldevidenceprospectiveregistryoftagraxofuspacd123directedtherapyforthetreatmentoffirstlineadultpatientswithblasticplasmacytoiddendriticcellneoplasm |